Evidence map›Paper›PMID 31342067›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa.

Kristin N Nelson, Samuel M Jenness, Barun Mathema, Benjamin A Lopman, Sara C Auld, N Sarita Shah, James C M Brust, Nazir Ismail, Shaheed Vally Omar, Tyler S Brown and 5 more

Open access · greenAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Kristin N NelsonRollins School of Public Health, Emory University, Atlanta, Georgia.
Samuel M JennessRollins School of Public Health, Emory University, Atlanta, Georgia.
Barun MathemaMailman School of Public Health, Columbia University, New York, New York.
Benjamin A LopmanRollins School of Public Health, Emory University, Atlanta, Georgia.
Sara C AuldRollins School of Public Health, Emory University, Atlanta, Georgia.
N Sarita ShahUS Centers for Disease Control and Prevention, Atlanta, Georgia.
James C M BrustAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York.
Nazir IsmailNational Institute for Communicable Diseases, Johannesburg, South Africa.
Shaheed Vally OmarNational Institute for Communicable Diseases, Johannesburg, South Africa.
Tyler S BrownMassachusetts General Hospital, Infectious Diseases Division, Boston.
Salim AllanaRollins School of Public Health, Emory University, Atlanta, Georgia.
Angie CampbellRollins School of Public Health, Emory University, Atlanta, Georgia.
Pravi MoodleyNational Health Laboratory Service, Durban, South Africa.
Koleka MlisanaNational Health Laboratory Service, Durban, South Africa.
Neel R GandhiRollins School of Public Health, Emory University, Atlanta, Georgia.
Emory University · USCenters for Disease Control and Prevention · USColumbia University · USMassachusetts General Hospital · USMontefiore Medical Center · USNational Health Laboratory Service · ZANational Institute for Communicable DiseasesUniversity of KwaZulu-Natal · ZAUniversity of Pretoria · ZA

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Kathryn M. Anastos · 2017 to 2026
$28.3M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TBR01AI087465 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.9M
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network StudyR01AI138646 · NIAID · EMORY UNIVERSITY · PI NAIDOO, KOGIELEUM, SHAH, NIPPIE SARITA · 2018 to 2022
$3.8M
Transmission of HIV-Associated XDR TB in Rural South AfricaR01AI089349 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.7M
Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIVR01AI114304 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRUST, JAMES C M · 2015 to 2019
$3.7M
EpiModel 2.0: Integrated Network Models for HIV/STI Prevention ScienceR01AI138783 · NIAID · EMORY UNIVERSITY · PI JENNESS, SAMUEL · 2018 to 2021
$3.0M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
Impact of HIV infection on early responses to TB exposureK23AI134182 · NIAID · EMORY UNIVERSITY · PI AULD, SARA · 2018 to 2023
$972k
NCATS NIH HHS UL1 TR001073NIAID NIH HHS K23 AI134182NIAID NIH HHS K24 AI114444NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI124414NIAID NIH HHS R01 AI087465NIAID NIH HHS R01 AI089349NIAID NIH HHS R01 AI114304NIAID NIH HHS R01 AI138646NIAID NIH HHS R01 AI138783
6 · The paper itself

Abstract

backgroundTuberculosis (TB) is the leading infectious cause of death globally, and drug-resistant TB strains pose a serious threat to controlling the global TB epidemic. The clinical features, locations, and social factors driving transmission in settings with high incidences of drug-resistant TB are poorly understood.

methodsWe measured a network of genomic links using Mycobacterium tuberculosis whole-genome sequences.

resultsPatients with 2-3 months of cough or who spent time in urban locations were more likely to be linked in the network, while patients with sputum smear-positive disease were less likely to be linked than those with smear-negative disease. Associations persisted using different thresholds to define genomic links and irrespective of assumptions about the direction of transmission.

conclusionsIdentifying factors that lead to many transmissions, including contact with urban areas, can suggest settings instrumental in transmission and indicate optimal locations and groups to target with interventions.

Indexed as

Extensively Drug-Resistant TuberculosisMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansSouth AfricaAntitubercular Agentsdrug-resistant tuberculosisnetwork modelstransmission networkstuberculosis transmissionwhole genome sequencing

Identifiers

PMID31342067
PMCPMC7245156
OpenAlexW2981976158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.